Vereecken, Pierre <br/><br/>
Is serum galectin-3 a potential predictor of the response to active specific immunotherapy in melanoma patients?  [electronic resource] 

 -  Journal of the European Academy of Dermatology and Venereology : JEADV  Feb 2007 
 - 278-80 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0926-9959 
<br/><br/><label>Standard No.: </label>10.1111/j.1468-3083.2006.01853.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biomarkers, Tumor--blood<br/>Enzyme-Linked Immunosorbent Assay<br/>Galectin 3--blood<br/>Humans<br/>Immunotherapy, Active--methods<br/>Melanoma--blood<br/>Skin Neoplasms--blood<br/>Statistics, Nonparametric